SCHEMBL16233178

SCHEMBL16233178

CN1CCN(C2(CNC(=O)c3ccc(OCc4ccccc4)cc3)CCOCC2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.60
HCN1 O60741 6/20 0.57
HCN4 Q9Y3Q4 4/20 0.55
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPK1 P28482 1/20 0.53
HSD17B10 Q99714 1/20 0.53
ALDH1A1 P00352 1/20 0.51
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16233199 0.92 LMNA (0.56) TP53HCN4MEN1KMT2AALDH1A1
SCHEMBL16233192 0.90 TP53 (0.73) TP53HCN1HCN4MEN1KMT2A
SCHEMBL16233193 0.86 HCN1 (0.53) TP53HCN1HCN4LMNAOPRM1
SCHEMBL16233200 0.85 TP53 (0.81) TP53HCN1MEN1KMT2AHSD17B10
SCHEMBL16233170 0.84 SLC6A5 (0.61) TP53HCN1HCN4ALDH1A1
SCHEMBL16233221 0.82 SLC6A5 (0.57) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL16510718 0.81 TP53 (0.66) TP53HCN1HCN4MEN1KMT2A
SCHEMBL16233227 0.81 MEN1 (0.57) TP53HCN1MEN1KMT2AMAPK1
SCHEMBL16233252 0.80 ALDH1A1 (0.56) MEN1KMT2AALDH1A1LMNACYP1A2
SCHEMBL16233181 0.79 TDP1 (0.49) HCN1HCN4ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359346-B2 Benzamide derivative and use thereof VIVOZON, INC. (KR) 2016-06-07 US disclosed
US-9359346-B2 Benzamide derivative and use thereof VIVOZON, INC. (KR) 2016-06-07 US disclosed
US-20140336378-A1 NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF VIVOZON, INC. (KR) 2014-11-13 US disclosed
US-20140336378-A1 NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF VIVOZON, INC. (KR) 2014-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336378-A1 NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF TRPV1, TRPA1, TRPV5 TP53 4562/4885HCN1 253/4885HCN4 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.